ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Budesonide Aerosol Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-8I7313
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Budesonide Aerosol Market Insights and Forecast to 2028
BUY CHAPTERS

Global Budesonide Aerosol Market Research Report 2025

Code: QYRE-Auto-8I7313
Report
August 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
Pfizer Inc
TEVA
Cipla Ltd
Novartis
Mylan NV
Abbott
Takeda
Boehringer Ingelheim
Allgen Pharmaceuticals
Squibb
Sandoz Inc
Shimadzu Corp
Manus Aktteva Biopharma LLP
Skyepharma
Shanghai Sine Pharmaceutical
Lunan Better Pharmaceutical
Wellcome Australia Ltd
Synmosa Biopharma Corporation
Chiesi Farmaceutici

Budesonide Aerosol Market Size

The global market for Budesonide Aerosol was valued at US$ 2398 million in the year 2024 and is projected to reach a revised size of US$ 12300 million by 2031, growing at a CAGR of 26.7% during the forecast period.

Budesonide Aerosol Market

Budesonide Aerosol Market

North American market for Budesonide Aerosol is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Budesonide Aerosol is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Budesonide Aerosol include AstraZeneca, Pfizer, Teva, Cipla, Novartis, Mylan, Abbott, Takeda, Boehringer Ingelheim, Allgen Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Budesonide Aerosol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Budesonide Aerosol.
The Budesonide Aerosol market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Budesonide Aerosol market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Budesonide Aerosol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Budesonide Aerosol Market Report

Report Metric Details
Report Name Budesonide Aerosol Market
Accounted market size in year US$ 2398 million
Forecasted market size in 2031 US$ 12300 million
CAGR 26.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 50ug/200 Spray
  • 100ug/200 Spray
  • 200ug/100 Spray
  • Other
Segment by Application
  • Hospitals
  • Clinics
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca, Pfizer, Teva, Cipla, Novartis, Mylan, Abbott, Takeda, Boehringer Ingelheim, Allgen Pharmaceuticals, Squibb, Sandoz, Shimadzu Corp, Manus Aktteva Biopharma LLP, Skyepharma, Shanghai Sine Pharmaceutical, Lunan Better Pharmaceutical, Wellcome Australia Ltd, Synmosa Biopharma Corporation, Chiesi Farmaceutici S.p.A
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Budesonide Aerosol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Budesonide Aerosol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Budesonide Aerosol Market growing?

Ans: The Budesonide Aerosol Market witnessing a CAGR of 26.7% during the forecast period 2025-2031.

What is the Budesonide Aerosol Market size in 2031?

Ans: The Budesonide Aerosol Market size in 2031 will be US$ 12300 million.

Who are the main players in the Budesonide Aerosol Market report?

Ans: The main players in the Budesonide Aerosol Market are AstraZeneca, Pfizer, Teva, Cipla, Novartis, Mylan, Abbott, Takeda, Boehringer Ingelheim, Allgen Pharmaceuticals, Squibb, Sandoz, Shimadzu Corp, Manus Aktteva Biopharma LLP, Skyepharma, Shanghai Sine Pharmaceutical, Lunan Better Pharmaceutical, Wellcome Australia Ltd, Synmosa Biopharma Corporation, Chiesi Farmaceutici S.p.A

What are the Application segmentation covered in the Budesonide Aerosol Market report?

Ans: The Applications covered in the Budesonide Aerosol Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Budesonide Aerosol Market report?

Ans: The Types covered in the Budesonide Aerosol Market report are 50ug/200 Spray, 100ug/200 Spray, 200ug/100 Spray, Other

Recommended Reports

Respiratory Drug Market

Asthma & Allergy Therapies

Pulmonary Devices & Delivery

1 Budesonide Aerosol Market Overview
1.1 Product Definition
1.2 Budesonide Aerosol by Type
1.2.1 Global Budesonide Aerosol Market Value Comparison by Type (2024 VS 2031)
1.2.2 50ug/200 Spray
1.2.3 100ug/200 Spray
1.2.4 200ug/100 Spray
1.2.5 Other
1.3 Budesonide Aerosol by Application
1.3.1 Global Budesonide Aerosol Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Budesonide Aerosol Market Size Estimates and Forecasts
1.4.1 Global Budesonide Aerosol Revenue 2020-2031
1.4.2 Global Budesonide Aerosol Sales 2020-2031
1.4.3 Global Budesonide Aerosol Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Budesonide Aerosol Market Competition by Manufacturers
2.1 Global Budesonide Aerosol Sales Market Share by Manufacturers (2020-2025)
2.2 Global Budesonide Aerosol Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Budesonide Aerosol Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Budesonide Aerosol, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Budesonide Aerosol, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Budesonide Aerosol, Product Type & Application
2.7 Global Key Manufacturers of Budesonide Aerosol, Date of Enter into This Industry
2.8 Global Budesonide Aerosol Market Competitive Situation and Trends
2.8.1 Global Budesonide Aerosol Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Budesonide Aerosol Players Market Share by Revenue
2.8.3 Global Budesonide Aerosol Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Budesonide Aerosol Market Scenario by Region
3.1 Global Budesonide Aerosol Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Budesonide Aerosol Sales by Region: 2020-2031
3.2.1 Global Budesonide Aerosol Sales by Region: 2020-2025
3.2.2 Global Budesonide Aerosol Sales by Region: 2026-2031
3.3 Global Budesonide Aerosol Revenue by Region: 2020-2031
3.3.1 Global Budesonide Aerosol Revenue by Region: 2020-2025
3.3.2 Global Budesonide Aerosol Revenue by Region: 2026-2031
3.4 North America Budesonide Aerosol Market Facts & Figures by Country
3.4.1 North America Budesonide Aerosol Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Budesonide Aerosol Sales by Country (2020-2031)
3.4.3 North America Budesonide Aerosol Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Budesonide Aerosol Market Facts & Figures by Country
3.5.1 Europe Budesonide Aerosol Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Budesonide Aerosol Sales by Country (2020-2031)
3.5.3 Europe Budesonide Aerosol Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Budesonide Aerosol Market Facts & Figures by Region
3.6.1 Asia Pacific Budesonide Aerosol Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Budesonide Aerosol Sales by Region (2020-2031)
3.6.3 Asia Pacific Budesonide Aerosol Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Budesonide Aerosol Market Facts & Figures by Country
3.7.1 Latin America Budesonide Aerosol Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Budesonide Aerosol Sales by Country (2020-2031)
3.7.3 Latin America Budesonide Aerosol Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Budesonide Aerosol Market Facts & Figures by Country
3.8.1 Middle East and Africa Budesonide Aerosol Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Budesonide Aerosol Sales by Country (2020-2031)
3.8.3 Middle East and Africa Budesonide Aerosol Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Budesonide Aerosol Sales by Type (2020-2031)
4.1.1 Global Budesonide Aerosol Sales by Type (2020-2025)
4.1.2 Global Budesonide Aerosol Sales by Type (2026-2031)
4.1.3 Global Budesonide Aerosol Sales Market Share by Type (2020-2031)
4.2 Global Budesonide Aerosol Revenue by Type (2020-2031)
4.2.1 Global Budesonide Aerosol Revenue by Type (2020-2025)
4.2.2 Global Budesonide Aerosol Revenue by Type (2026-2031)
4.2.3 Global Budesonide Aerosol Revenue Market Share by Type (2020-2031)
4.3 Global Budesonide Aerosol Price by Type (2020-2031)
5 Segment by Application
5.1 Global Budesonide Aerosol Sales by Application (2020-2031)
5.1.1 Global Budesonide Aerosol Sales by Application (2020-2025)
5.1.2 Global Budesonide Aerosol Sales by Application (2026-2031)
5.1.3 Global Budesonide Aerosol Sales Market Share by Application (2020-2031)
5.2 Global Budesonide Aerosol Revenue by Application (2020-2031)
5.2.1 Global Budesonide Aerosol Revenue by Application (2020-2025)
5.2.2 Global Budesonide Aerosol Revenue by Application (2026-2031)
5.2.3 Global Budesonide Aerosol Revenue Market Share by Application (2020-2031)
5.3 Global Budesonide Aerosol Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Budesonide Aerosol Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Budesonide Aerosol Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teva Budesonide Aerosol Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Company Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cipla Budesonide Aerosol Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Company Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis Budesonide Aerosol Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Company Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Mylan Budesonide Aerosol Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Abbott
6.7.1 Abbott Company Information
6.7.2 Abbott Description and Business Overview
6.7.3 Abbott Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Abbott Budesonide Aerosol Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 Takeda
6.8.1 Takeda Company Information
6.8.2 Takeda Description and Business Overview
6.8.3 Takeda Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Takeda Budesonide Aerosol Product Portfolio
6.8.5 Takeda Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Company Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Boehringer Ingelheim Budesonide Aerosol Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 Allgen Pharmaceuticals
6.10.1 Allgen Pharmaceuticals Company Information
6.10.2 Allgen Pharmaceuticals Description and Business Overview
6.10.3 Allgen Pharmaceuticals Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Allgen Pharmaceuticals Budesonide Aerosol Product Portfolio
6.10.5 Allgen Pharmaceuticals Recent Developments/Updates
6.11 Squibb
6.11.1 Squibb Company Information
6.11.2 Squibb Description and Business Overview
6.11.3 Squibb Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Squibb Budesonide Aerosol Product Portfolio
6.11.5 Squibb Recent Developments/Updates
6.12 Sandoz
6.12.1 Sandoz Company Information
6.12.2 Sandoz Description and Business Overview
6.12.3 Sandoz Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sandoz Budesonide Aerosol Product Portfolio
6.12.5 Sandoz Recent Developments/Updates
6.13 Shimadzu Corp
6.13.1 Shimadzu Corp Company Information
6.13.2 Shimadzu Corp Description and Business Overview
6.13.3 Shimadzu Corp Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shimadzu Corp Budesonide Aerosol Product Portfolio
6.13.5 Shimadzu Corp Recent Developments/Updates
6.14 Manus Aktteva Biopharma LLP
6.14.1 Manus Aktteva Biopharma LLP Company Information
6.14.2 Manus Aktteva Biopharma LLP Description and Business Overview
6.14.3 Manus Aktteva Biopharma LLP Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Manus Aktteva Biopharma LLP Budesonide Aerosol Product Portfolio
6.14.5 Manus Aktteva Biopharma LLP Recent Developments/Updates
6.15 Skyepharma
6.15.1 Skyepharma Company Information
6.15.2 Skyepharma Description and Business Overview
6.15.3 Skyepharma Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Skyepharma Budesonide Aerosol Product Portfolio
6.15.5 Skyepharma Recent Developments/Updates
6.16 Shanghai Sine Pharmaceutical
6.16.1 Shanghai Sine Pharmaceutical Company Information
6.16.2 Shanghai Sine Pharmaceutical Description and Business Overview
6.16.3 Shanghai Sine Pharmaceutical Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Shanghai Sine Pharmaceutical Budesonide Aerosol Product Portfolio
6.16.5 Shanghai Sine Pharmaceutical Recent Developments/Updates
6.17 Lunan Better Pharmaceutical
6.17.1 Lunan Better Pharmaceutical Company Information
6.17.2 Lunan Better Pharmaceutical Description and Business Overview
6.17.3 Lunan Better Pharmaceutical Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Lunan Better Pharmaceutical Budesonide Aerosol Product Portfolio
6.17.5 Lunan Better Pharmaceutical Recent Developments/Updates
6.18 Wellcome Australia Ltd
6.18.1 Wellcome Australia Ltd Company Information
6.18.2 Wellcome Australia Ltd Description and Business Overview
6.18.3 Wellcome Australia Ltd Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Wellcome Australia Ltd Budesonide Aerosol Product Portfolio
6.18.5 Wellcome Australia Ltd Recent Developments/Updates
6.19 Synmosa Biopharma Corporation
6.19.1 Synmosa Biopharma Corporation Company Information
6.19.2 Synmosa Biopharma Corporation Description and Business Overview
6.19.3 Synmosa Biopharma Corporation Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Synmosa Biopharma Corporation Budesonide Aerosol Product Portfolio
6.19.5 Synmosa Biopharma Corporation Recent Developments/Updates
6.20 Chiesi Farmaceutici S.p.A
6.20.1 Chiesi Farmaceutici S.p.A Company Information
6.20.2 Chiesi Farmaceutici S.p.A Description and Business Overview
6.20.3 Chiesi Farmaceutici S.p.A Budesonide Aerosol Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Chiesi Farmaceutici S.p.A Budesonide Aerosol Product Portfolio
6.20.5 Chiesi Farmaceutici S.p.A Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Budesonide Aerosol Industry Chain Analysis
7.2 Budesonide Aerosol Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Budesonide Aerosol Production Mode & Process Analysis
7.4 Budesonide Aerosol Sales and Marketing
7.4.1 Budesonide Aerosol Sales Channels
7.4.2 Budesonide Aerosol Distributors
7.5 Budesonide Aerosol Customer Analysis
8 Budesonide Aerosol Market Dynamics
8.1 Budesonide Aerosol Industry Trends
8.2 Budesonide Aerosol Market Drivers
8.3 Budesonide Aerosol Market Challenges
8.4 Budesonide Aerosol Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Astrazeneca plc
Pfizer Inc
TEVA
Cipla Ltd
Novartis
Mylan NV
Abbott
Takeda
Boehringer Ingelheim
Allgen Pharmaceuticals
Squibb
Sandoz Inc
Shimadzu Corp
Manus Aktteva Biopharma LLP
Skyepharma
Shanghai Sine Pharmaceutical
Lunan Better Pharmaceutical
Wellcome Australia Ltd
Synmosa Biopharma Corporation
Chiesi Farmaceutici
List of Tables
 Table 1. Global Budesonide Aerosol Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Budesonide Aerosol Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Budesonide Aerosol Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Budesonide Aerosol Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Budesonide Aerosol Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Budesonide Aerosol Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Budesonide Aerosol Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Budesonide Aerosol Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Budesonide Aerosol, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Budesonide Aerosol, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Budesonide Aerosol, Product Type & Application
 Table 12. Global Key Manufacturers of Budesonide Aerosol, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Budesonide Aerosol by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Budesonide Aerosol as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Budesonide Aerosol Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Budesonide Aerosol Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Budesonide Aerosol Sales Market Share by Region (2020-2025)
 Table 19. Global Budesonide Aerosol Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Budesonide Aerosol Sales Market Share by Region (2026-2031)
 Table 21. Global Budesonide Aerosol Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Budesonide Aerosol Revenue Market Share by Region (2020-2025)
 Table 23. Global Budesonide Aerosol Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Budesonide Aerosol Revenue Market Share by Region (2026-2031)
 Table 25. North America Budesonide Aerosol Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Budesonide Aerosol Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Budesonide Aerosol Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Budesonide Aerosol Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Budesonide Aerosol Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Budesonide Aerosol Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Budesonide Aerosol Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Budesonide Aerosol Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Budesonide Aerosol Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Budesonide Aerosol Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Budesonide Aerosol Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Budesonide Aerosol Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Budesonide Aerosol Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Budesonide Aerosol Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Budesonide Aerosol Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Budesonide Aerosol Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Budesonide Aerosol Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Budesonide Aerosol Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Budesonide Aerosol Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Budesonide Aerosol Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Budesonide Aerosol Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Budesonide Aerosol Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Budesonide Aerosol Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Budesonide Aerosol Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Budesonide Aerosol Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Budesonide Aerosol Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Budesonide Aerosol Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Budesonide Aerosol Sales Market Share by Type (2020-2025)
 Table 53. Global Budesonide Aerosol Sales Market Share by Type (2026-2031)
 Table 54. Global Budesonide Aerosol Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Budesonide Aerosol Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Budesonide Aerosol Revenue Market Share by Type (2020-2025)
 Table 57. Global Budesonide Aerosol Revenue Market Share by Type (2026-2031)
 Table 58. Global Budesonide Aerosol Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Budesonide Aerosol Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Budesonide Aerosol Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Budesonide Aerosol Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Budesonide Aerosol Sales Market Share by Application (2020-2025)
 Table 63. Global Budesonide Aerosol Sales Market Share by Application (2026-2031)
 Table 64. Global Budesonide Aerosol Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Budesonide Aerosol Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Budesonide Aerosol Revenue Market Share by Application (2020-2025)
 Table 67. Global Budesonide Aerosol Revenue Market Share by Application (2026-2031)
 Table 68. Global Budesonide Aerosol Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Budesonide Aerosol Price (USD/Pcs) by Application (2026-2031)
 Table 70. AstraZeneca Company Information
 Table 71. AstraZeneca Description and Business Overview
 Table 72. AstraZeneca Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. AstraZeneca Budesonide Aerosol Product
 Table 74. AstraZeneca Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Pfizer Budesonide Aerosol Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Teva Company Information
 Table 81. Teva Description and Business Overview
 Table 82. Teva Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Teva Budesonide Aerosol Product
 Table 84. Teva Recent Developments/Updates
 Table 85. Cipla Company Information
 Table 86. Cipla Description and Business Overview
 Table 87. Cipla Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Cipla Budesonide Aerosol Product
 Table 89. Cipla Recent Developments/Updates
 Table 90. Novartis Company Information
 Table 91. Novartis Description and Business Overview
 Table 92. Novartis Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Novartis Budesonide Aerosol Product
 Table 94. Novartis Recent Developments/Updates
 Table 95. Mylan Company Information
 Table 96. Mylan Description and Business Overview
 Table 97. Mylan Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Mylan Budesonide Aerosol Product
 Table 99. Mylan Recent Developments/Updates
 Table 100. Abbott Company Information
 Table 101. Abbott Description and Business Overview
 Table 102. Abbott Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Abbott Budesonide Aerosol Product
 Table 104. Abbott Recent Developments/Updates
 Table 105. Takeda Company Information
 Table 106. Takeda Description and Business Overview
 Table 107. Takeda Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Takeda Budesonide Aerosol Product
 Table 109. Takeda Recent Developments/Updates
 Table 110. Boehringer Ingelheim Company Information
 Table 111. Boehringer Ingelheim Description and Business Overview
 Table 112. Boehringer Ingelheim Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Boehringer Ingelheim Budesonide Aerosol Product
 Table 114. Boehringer Ingelheim Recent Developments/Updates
 Table 115. Allgen Pharmaceuticals Company Information
 Table 116. Allgen Pharmaceuticals Description and Business Overview
 Table 117. Allgen Pharmaceuticals Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Allgen Pharmaceuticals Budesonide Aerosol Product
 Table 119. Allgen Pharmaceuticals Recent Developments/Updates
 Table 120. Squibb Company Information
 Table 121. Squibb Description and Business Overview
 Table 122. Squibb Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Squibb Budesonide Aerosol Product
 Table 124. Squibb Recent Developments/Updates
 Table 125. Sandoz Company Information
 Table 126. Sandoz Description and Business Overview
 Table 127. Sandoz Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Sandoz Budesonide Aerosol Product
 Table 129. Sandoz Recent Developments/Updates
 Table 130. Shimadzu Corp Company Information
 Table 131. Shimadzu Corp Description and Business Overview
 Table 132. Shimadzu Corp Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Shimadzu Corp Budesonide Aerosol Product
 Table 134. Shimadzu Corp Recent Developments/Updates
 Table 135. Manus Aktteva Biopharma LLP Company Information
 Table 136. Manus Aktteva Biopharma LLP Description and Business Overview
 Table 137. Manus Aktteva Biopharma LLP Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 138. Manus Aktteva Biopharma LLP Budesonide Aerosol Product
 Table 139. Manus Aktteva Biopharma LLP Recent Developments/Updates
 Table 140. Skyepharma Company Information
 Table 141. Skyepharma Description and Business Overview
 Table 142. Skyepharma Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 143. Skyepharma Budesonide Aerosol Product
 Table 144. Skyepharma Recent Developments/Updates
 Table 145. Shanghai Sine Pharmaceutical Company Information
 Table 146. Shanghai Sine Pharmaceutical Description and Business Overview
 Table 147. Shanghai Sine Pharmaceutical Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 148. Shanghai Sine Pharmaceutical Budesonide Aerosol Product
 Table 149. Shanghai Sine Pharmaceutical Recent Developments/Updates
 Table 150. Lunan Better Pharmaceutical Company Information
 Table 151. Lunan Better Pharmaceutical Description and Business Overview
 Table 152. Lunan Better Pharmaceutical Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 153. Lunan Better Pharmaceutical Budesonide Aerosol Product
 Table 154. Lunan Better Pharmaceutical Recent Developments/Updates
 Table 155. Wellcome Australia Ltd Company Information
 Table 156. Wellcome Australia Ltd Description and Business Overview
 Table 157. Wellcome Australia Ltd Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 158. Wellcome Australia Ltd Budesonide Aerosol Product
 Table 159. Wellcome Australia Ltd Recent Developments/Updates
 Table 160. Synmosa Biopharma Corporation Company Information
 Table 161. Synmosa Biopharma Corporation Description and Business Overview
 Table 162. Synmosa Biopharma Corporation Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 163. Synmosa Biopharma Corporation Budesonide Aerosol Product
 Table 164. Synmosa Biopharma Corporation Recent Developments/Updates
 Table 165. Chiesi Farmaceutici S.p.A Company Information
 Table 166. Chiesi Farmaceutici S.p.A Description and Business Overview
 Table 167. Chiesi Farmaceutici S.p.A Budesonide Aerosol Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 168. Chiesi Farmaceutici S.p.A Budesonide Aerosol Product
 Table 169. Chiesi Farmaceutici S.p.A Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Budesonide Aerosol Distributors List
 Table 173. Budesonide Aerosol Customers List
 Table 174. Budesonide Aerosol Market Trends
 Table 175. Budesonide Aerosol Market Drivers
 Table 176. Budesonide Aerosol Market Challenges
 Table 177. Budesonide Aerosol Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Budesonide Aerosol
 Figure 2. Global Budesonide Aerosol Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Budesonide Aerosol Market Share by Type: 2024 & 2031
 Figure 4. 50ug/200 Spray Product Picture
 Figure 5. 100ug/200 Spray Product Picture
 Figure 6. 200ug/100 Spray Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Budesonide Aerosol Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Budesonide Aerosol Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Clinics
 Figure 12. Other
 Figure 13. Global Budesonide Aerosol Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Budesonide Aerosol Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Budesonide Aerosol Sales (2020-2031) & (K Pcs)
 Figure 16. Global Budesonide Aerosol Average Price (USD/Pcs) & (2020-2031)
 Figure 17. Budesonide Aerosol Report Years Considered
 Figure 18. Budesonide Aerosol Sales Share by Manufacturers in 2024
 Figure 19. Global Budesonide Aerosol Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Budesonide Aerosol Players: Market Share by Revenue in Budesonide Aerosol in 2024
 Figure 21. Budesonide Aerosol Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Budesonide Aerosol Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Budesonide Aerosol Sales Market Share by Country (2020-2031)
 Figure 24. North America Budesonide Aerosol Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Budesonide Aerosol Sales Market Share by Country (2020-2031)
 Figure 28. Europe Budesonide Aerosol Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Budesonide Aerosol Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Budesonide Aerosol Revenue Market Share by Region (2020-2031)
 Figure 36. China Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Budesonide Aerosol Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Budesonide Aerosol Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Budesonide Aerosol Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Budesonide Aerosol Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Budesonide Aerosol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Budesonide Aerosol by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Budesonide Aerosol by Type (2020-2031)
 Figure 57. Global Budesonide Aerosol Price (USD/Pcs) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Budesonide Aerosol by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Budesonide Aerosol by Application (2020-2031)
 Figure 60. Global Budesonide Aerosol Price (USD/Pcs) by Application (2020-2031)
 Figure 61. Budesonide Aerosol Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Budesonide Nasal Spray Market Research Report 2024
Global Budesonide Commercial Medicine Market Research Report 2025
Budesonide API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inhaler Corticosteroid Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Aerosol Spray Market Insights Forecast to 2030
Medical Aerosol Adsorber Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pulmicort Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Aerosol Adsorber Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Beclomethasone Dipropionate Aerosols Market Research Report 2025
DME Aerosol Propellant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Aerosol Packaging Market Research Report 2025
Global Aerosol Paints Market Research Report 2025
Global Pharmaceutical Aerosol Market Research Report 2024
Global Inhalation Aerosol Market Research Report 2025
Global Aerosol Lubricant Market Research Report 2025
Global Aerosol Mask Market Research Report 2024
Global Budesonide Inhaler Market Research Report 2024
Global Aerosol for Air Care Market Research Report 2024
Global Aerosol Therapy Device Market Research Report 2025
Corticosteroids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions